MoleSense is developing a skin patch that continuously monitors biomarkers to track high-risk pregnancies. The FIT has granted it a CHF 100,000 Tech Seed loan to build a first prototype and carry out preclinical testing.
- Announced on
- Round
- Loan
- Amount
- CHF 100,000
- Location
- Epalinges, canton of Vaud
- Sector
- Health & medtech
Investors
- FIT Vaud (Innovaud) lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic